These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 22447678)

  • 21. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
    Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
    J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
    Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex Patterns of GABAergic Neuronal Deficiency and Type 2 Potassium-Chloride Cotransporter Immaturity in Human Focal Cortical Dysplasia.
    Han P; Welsh CT; Smith MT; Schmidt RE; Carroll SL
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):365-372. PubMed ID: 30856249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
    Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
    Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
    Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
    J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations.
    Zimmer TS; Ciriminna G; Arena A; Anink JJ; Korotkov A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Baayen JC; Idema S; Rensing NR; Wong M; Mills JD; van Vliet EA; Aronica E
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):546-563. PubMed ID: 31869431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
    Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
    Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
    Kimura T; Kitaura H; Masuda H; Kameyama S; Saito Y; Sugai K; Otsuki T; Nakazawa A; Morota N; Yamamoto T; Iida K; Nakagawa M; Mizuno T; Takahashi H; Kakita A
    Neuropathology; 2015 Oct; 35(5):401-9. PubMed ID: 25950494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions.
    Prabowo AS; Iyer AM; Anink JJ; Spliet WG; van Rijen PC; Aronica E
    J Neuroinflammation; 2013 Jan; 10():12. PubMed ID: 23347564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
    Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
    Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
    Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
    Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia.
    Finardi A; Colciaghi F; Castana L; Locatelli D; Marras CE; Nobili P; Fratelli M; Bramerio MA; Lorusso G; Battaglia GS
    Acta Neuropathol; 2013 Aug; 126(2):219-35. PubMed ID: 23793416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR pathway activation in focal cortical dysplasia.
    Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia.
    Hulshof HM; Benova B; Krsek P; Kyncl M; Lequin MH; Belohlavkova A; Jezdik P; Braun KPJ; Jansen FE
    Epilepsia Open; 2021 Dec; 6(4):663-671. PubMed ID: 34328682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
    Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
    Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of GABAergic neurons and abnormality of NKCC1/KCC2 in focal cortical dysplasia (FCD) type Ⅱ lesions.
    Yan L; Yun-Lin L; Yong-Ling L; Wei-Wei Z; Yue-Shan P
    Epilepsy Res; 2023 Aug; 194():107180. PubMed ID: 37352729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of age at seizure onset with GABA
    Sharma D; Tripathi M; Doddamani R; Sharma MC; Lalwani S; Sarat Chandra P; Banerjee Dixit A; Banerjee J
    Neurosci Lett; 2023 Feb; 796():137065. PubMed ID: 36638954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
    Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.